A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

NYU Langone Medical Center, New York

NYU Winthrop Hospital, Mineola

UPMC Presbyterian, Pittsburgh

St. Luke's Cardiology Associates, Bethlehem

University of Pennsylvania, Philadelphia

University of Maryland Medical System, Baltimore

University of Virginia, Charlottesville

Virginia Commonwealth University, Richmond

Duke Cardiology at Southpoint, Durham

Carolinas Medical Center, Charlotte

University of Cincinnati Medical Center, Cincinnati

St. Vincent Medical Group, Indianapolis

Michigan Medicine, Ann Arbor

Henry Ford Hospital, Detroit

University of Iowa Hospitals and clinics, Iowa City

Unity Point Health Meriter Heart and Vascular Institute, Madison

Northwestern University, Evanston

Washington University School of Medicine, St Louis

Baylor St. Luke Medical Center at Houston, Texas Heart Institute Out-patient Clinic, Houston

Houston Methodist Hospital, Houston

Intermountain Medical Center, Murray

University of Utah Medical Center, Salt Lake City

Mayo Clinic Arizona, Scottsdale

Cedars-Sinai Medical Center (Smidt Heart Institute), Los Angeles

University of California, San Francisco, San Francisco

Stanford Hospital and Clinics/Stanford University, Palo Alto

Oregon Health and Science University, Portland

University of Washington Medical Center, Seattle

Yale New Haven Hospital, New Haven

Brigham and Women's Hospital, Boston

Penn State Health Milton S. Hershey Medical Center, Hershey

The University of Texas Southwestern Medical Center at Dallas, Dallas